Copyright © 2023 Ambrx. All Rights Reserved | Privacy | Site Map | Terms of Use
Progress, News, and Updates
Read about our latest strides in precision biologics innovation. Stay in the know with our advancements through timely news, presentations, thought-provoking events, and insightful glimpses into the future.
Read here for a description of the expanded genetic code technology featured in Nature.
Latest News
Ambrx to Participate in the Cantor Fitzgerald Global Healthcare Conference
Focused Oncology Portfolio
We are advancing enhanced antibody-drug conjugate, immuno-oncology conjugate and bispecific candidates as potential treatments for cancer.
Expanded Genetic Code Technology Platform
We incorporate synthetic amino acids into proteins within living cells. The result? Product candidates designed for highly stable, site-specific conjugation, overcoming the inherent limitations of conventional conjugation approaches.